Healthcare M&A in New York runs on sector expertise. This list covers 11 firms active in pharma, biotech, health services, and medtech deals in 2026 - with deal sizes and sector focus.
What sets healthcare M&A apart
Healthcare deals carry regulatory, reimbursement, and compliance risk that generalist advisors often miss. You need a firm that understands FDA pathways, CMS reimbursement, and HIPAA implications.
Buyer diligence in healthcare goes deeper than financials. Expect questions on payer mix, patient concentration, regulatory filings, and pending litigation before any LOI gets signed.
Your advisor needs to frame your business in clinical and operational terms - not just EBITDA. The right framing determines which strategic buyers show up and how they value you.
Ellty lets you build a virtual data room before your first advisor meeting. Upload clinical data, compliance records, and financials, then share each section with specific buyers as diligence progresses.
| Deal Type | Deal Size | Sector Focus | Website | |
|---|---|---|---|---|
| Leerink Partners | Both | $100M-$10B+ | Biopharma, medtech, diagnostics, healthcare services | leerink.com |
| Centerview Partners | Both | $1B-$100B+ | Biopharma, large-cap pharma M&A, board advisory | centerviewpartners.com |
| Houlihan Lokey | Both | $50M-$5B+ | Healthcare services, medtech, pharma, health IT | hl.com |
| Jefferies | Both | $100M-$10B+ | Biotech, specialty pharma, medtech, health services, health IT | jefferies.com |
| Guggenheim Securities | Both | $250M-$50B+ | Pharma, biotech, diagnostics, medical devices | guggenheimpartners.com |
| Piper Sandler | Both | $50M-$2B+ | Healthcare services, behavioral health, specialty pharma | pipersandler.com |
| Solomon Partners | Both | $50M-$1B+ | Healthcare services, medical products, life sciences | solomonpartners.com |
| Kaufman Hall | Both | $50M-$5B+ | Hospitals, health systems, physician groups, health plans | kaufmanhall.com |
| VERTESS | Both | $5M-$250M | Behavioral health, home care, hospice, dental, DME | vertess.com |
| M&A Healthcare Advisors | Both | $5M-$100M | Physician practices, specialty clinics, outpatient care | mahealthcareadvisors.com |
| TripleTree | Both | $50M-$2B+ | Health IT, digital health, population health, value-based care | triple-tree.com |
Healthcare M&A regulatory basics
Healthcare deals face regulatory scrutiny that most other sectors don't. Every deal touching Medicare or Medicaid reimbursement needs counsel familiar with anti-kickback statute and Stark Law implications.
FTC and DOJ review timelines for healthcare deals stretched past 12 months on several transactions in 2025. Build regulatory risk into your deal timeline and engagement letter from day one.
Physician practice acquisitions also trigger state-level corporate practice of medicine laws. Your advisor needs to know which state rules apply - and how to structure around them.
Use Ellty to share legal and compliance documents with your advisor under strict access controls. Separate folders for regulatory filings, compliance audits, and payer contracts keep diligence organized from the start.
Read the due diligence for acquisition guide before your first advisor call. Healthcare-specific items - payor contracts, FDA filings, CON approvals - add weeks to a standard diligence timeline.
Build your healthcare M&A data room
Organize clinical, compliance, and financial docs for healthcare buyers.
Start free 14-day trialWhat an M&A deal looks like: 6 stages
Healthcare deals take eight to twelve months on average. Regulatory filings and payor contract reviews add time that tech or industrial sellers don't face.
| What happens | What you need ready | |
|---|---|---|
| 1. Preparation | Valuation, advisor selection, CIM drafting | 3 years financials, payer mix, compliance records |
| 2. Advisor engagement | Engagement letter signed, process timeline set | Engagement letter, corporate records, licenses |
| 3. Marketing | Teaser and CIM sent to strategic and PE buyers | Ellty data room with gated document access ready |
| 4. LOI | Buyers submit bids, advisor selects shortlist | Management presentation, updated financials |
| 5. Due diligence | Buyer reviews legal, financial, and clinical records | Full data room: payor contracts, FDA filings, HR |
| 6. Close | Purchase agreement signed, funds transferred | Board approvals, regulatory filings, escrow setup |
11 New York healthcare M&A advisors in 2026
These firms are active across pharma, biotech, health services, medtech, and digital health in New York in 2026.
1. Leerink Partners
Leerink Partners is a healthcare-only investment bank with deep technical fluency across biopharma, medtech, diagnostics, and health services - rare expertise that generalist banks can't replicate.
Recent Deals: Active in biopharma advisory and capital markets through 2025-2026. Known for advising on strategic reviews, licensing deals, and M&A across biotech and specialty pharma.
LinkedIn: Leerink Partners on LinkedIn
Sector Focus: Biopharma, medtech, diagnostics, healthcare services, life sciences
Deal Type: Both
Deal Size: $100M-$10B+
Location: New York, NY (also Boston, San Francisco)
Website: leerink.com
2. Centerview Partners
Centerview Partners is the pre-eminent independent advisor on the largest, most complex biopharma M&A transactions. Senior partners stay on every mandate from pitch through close.
Recent Deals: Advised on major pharma strategic reviews and board-level M&A in 2025. Consistently ranked among top advisors on large-cap pharma and life sciences transactions.
LinkedIn: Centerview Partners on LinkedIn
Sector Focus: Large-cap biopharma M&A, board advisory, shareholder defense, pharma licensing
Deal Type: Both
Deal Size: $1B-$100B+
Location: New York, NY
Website: centerviewpartners.com
3. Houlihan Lokey
Houlihan Lokey's healthcare group is one of the most active in the country, covering M&A advisory, restructuring, and financial advisory across every healthcare subsector.
Recent Deals: Advised on UHS's $835M acquisition of Talkspace in 2025. Ranked among the top healthcare advisors globally for middle-market deal count in 2025.
LinkedIn: Houlihan Lokey on LinkedIn
Sector Focus: Healthcare services, medtech, pharma, health IT, restructuring
Deal Type: Both
Deal Size: $50M-$5B+
Location: New York, NY (multiple US and global offices)
Website: hl.com
4. Jefferies
Jefferies is one of the most important healthcare investment banks for 2026, combining sector expertise with capital markets, sponsor coverage, and M&A advisory across every healthcare subsector.
Recent Deals: Active in biotech and healthcare services M&A through 2025-2026. Advised on cross-border transactions and PE-backed healthcare exits in the US market.
LinkedIn: Jefferies on LinkedIn
Sector Focus: Biotech, specialty pharma, medtech, healthcare services, health IT
Deal Type: Both
Deal Size: $100M-$10B+
Location: New York, NY (global headquarters)
Website: jefferies.com
5. Guggenheim Securities
Guggenheim Securities advises on large-cap pharma, biotech, diagnostics, and medical device transactions where complex deal structures and board-level advice are required.
Recent Deals: Active in large-cap pharma and biotech advisory in 2025-2026. Has advised on some of the largest strategic transactions in the pharma sector in recent years.
LinkedIn: Guggenheim Securities on LinkedIn
Sector Focus: Pharma, biotech, diagnostics, medical devices, life sciences
Deal Type: Both
Deal Size: $250M-$50B+
Location: New York, NY
Website: guggenheimpartners.com
6. Piper Sandler
Piper Sandler covers the middle market in healthcare services, behavioral health, and specialty pharma. Its deal team stays involved through close, not just the pitch.
Recent Deals: Active in healthcare services and behavioral health M&A advisory through 2025-2026. Regularly advises on PE-backed healthcare services exits and platform builds.
LinkedIn: Piper Sandler on LinkedIn
Sector Focus: Healthcare services, behavioral health, specialty pharma, health IT
Deal Type: Both
Deal Size: $50M-$2B+
Location: New York, NY (multiple US offices)
Website: pipersandler.com
Build your healthcare M&A data room
Organize clinical, compliance, and financial docs for healthcare buyers.
Start free 14-day trial7. Solomon Partners
Solomon Partners is a New York-headquartered independent advisory firm handling healthcare services, medical products, and life sciences transactions with senior partner involvement throughout.
Recent Deals: Active in healthcare M&A advisory through 2025-2026. Handles transactions across 12+ verticals including healthcare services and medical products for sellers and buyers.
LinkedIn: Solomon Partners on LinkedIn
Sector Focus: Healthcare services, medical products, life sciences, consumer health
Deal Type: Both
Deal Size: $50M-$1B+
Location: New York, NY (1345 Avenue of the Americas)
Website: solomonpartners.com
8. Kaufman Hall
Kaufman Hall advises hospitals, health systems, physician groups, and health plans. If you're in provider-side healthcare, this is the firm with the deepest transaction network.
Recent Deals: Active in hospital system M&A advisory and health plan transactions through 2025-2026. Tracks health system deal activity with quarterly M&A reports.
LinkedIn: Kaufman Hall on LinkedIn
Sector Focus: Hospitals, health systems, physician groups, specialty providers, health plans
Deal Type: Both
Deal Size: $50M-$5B+
Location: New York, NY (also Chicago and other US offices)
Website: kaufmanhall.com
9. VERTESS
VERTESS is a healthcare-only M&A advisory firm covering behavioral health, home care, hospice, dental, DME, pharmacies, urgent care, and life sciences - sectors most generalist advisors won't touch.
Recent Deals: Active in behavioral health, home care, and specialty services M&A through 2025-2026. Covers lower middle market healthcare services transactions that larger banks pass on.
LinkedIn: VERTESS on LinkedIn
Sector Focus: Behavioral health, home care, hospice, dental, DME, pharmacies, urgent care
Deal Type: Both
Deal Size: $5M-$250M
Location: New York, NY (national coverage)
Website: vertess.com
10. M&A Healthcare Advisors
M&A Healthcare Advisors focuses exclusively on physician practice and specialty clinic transactions. If you're selling a medical practice, this team knows the buyer landscape better than most.
Recent Deals: Active in physician practice acquisitions and specialty clinic M&A through 2025-2026. Covers outpatient care, imaging centers, and specialty practices across the US.
LinkedIn: M&A Healthcare Advisors on LinkedIn
Sector Focus: Physician practices, specialty clinics, outpatient care, imaging centers
Deal Type: Both
Deal Size: $5M-$100M
Location: New York, NY
Website: mahealthcareadvisors.com
11. TripleTree
TripleTree is a healthcare-focused investment bank covering health IT, digital health, and value-based care - sectors where clinical, operational, and technology expertise all have to come together.
Recent Deals: Published "The Health of Healthcare M&A 2025" report tracking deal trends. Active in health IT and digital health M&A advisory through 2025-2026.
LinkedIn: TripleTree on LinkedIn
Sector Focus: Health IT, digital health, population health, value-based care, health analytics
Deal Type: Both
Deal Size: $50M-$2B+
Location: Minneapolis, MN (national coverage, active New York market)
Website: triple-tree.com
How advisors value a healthcare business
Healthcare valuations hinge on revenue quality, not just revenue size. Payer mix, reimbursement rates, contract renewal risk, and regulatory compliance all adjust your multiple up or down.
EBITDA multiples in healthcare services range from 6x to 14x depending on subsector and growth profile. Specialty practices with strong fee-for-service or capitation contracts often trade at the high end.
Your advisor should build a detailed reimbursement bridge in the CIM. Buyers need to see how revenue splits across Medicare, Medicaid, commercial, and self-pay - and how each segment trends.
Ellty helps you organize payer contracts and reimbursement schedules in a secure data room. Grant each buyer access to financial sections first - then open clinical records after LOI.
Read the due diligence documents guide before your advisor meeting. Understanding what buyers scrutinize in healthcare financials helps you package your numbers more effectively.
Healthcare-specific diligence items
Healthcare buyers dig into areas that standard M&A diligence never covers. Plan for questions on Medicare and Medicaid billing compliance, HIPAA security, and state licensing before you go to market.
Billing and coding audits are common in healthcare deals. A buyer will test your revenue cycle claims for upcoding, unbundling, and documentation gaps before signing a purchase agreement.
Joint Commission accreditation, CON approvals, DEA registrations, and state clinical licenses all transfer differently in an M&A context. Your advisor needs to flag these transfer requirements early.
Ellty's granular permissions let you share HIPAA-sensitive compliance files with specific buyers. Track every document open so you know exactly who reviewed what - useful for regulatory log requirements.
Read the operational due diligence guide before going to market. Healthcare operations - staffing, clinical workflows, billing systems - get scrutinized harder than most sellers expect.
Choosing a healthcare advisor by subsector
Biopharma and biotech sellers need advisors with clinical fluency - firms like Leerink, Centerview, and Guggenheim that can speak to pipeline valuation, clinical risk, and milestone structures.
Healthcare services - hospitals, physician practices, behavioral health, home care - need advisors with payer and regulatory knowledge. Kaufman Hall, VERTESS, and M&A Healthcare Advisors cover this sector best.
Digital health and health IT sellers need advisors who understand SaaS metrics and healthcare interoperability together. TripleTree and Piper Sandler have the most relevant track records in this subsector.
Use Ellty's secure file sharing to run a clean parallel process across subsector-specific buyers. Keep pharma and provider buyers in separate data room folders to prevent premature cross-disclosure.
Review the due diligence for private equity guide if PE is part of your buyer universe. Healthcare PE firms run specialized diligence playbooks you should understand before entering the process.
How Ellty helps you close a healthcare M&A deal
Your advisor shortlist is set. Open a data room before your first call.
- 1.Upload healthcare documents to a secure roomAdd financials, payor contracts, and compliance records now.
- 2.Set access rights for each buyer or advisorControl who sees clinical vs financial documents separately.
- 3.Track document opens to find serious buyersSee who reviews what and follow up with confidence.
Common questions about New York healthcare M&A advisors
- Most focus on one subsector - pharma, health services, or digital health. Pick the advisor whose closed deals match your business type.
- Expect eight to twelve months. Regulatory filings and payor contract reviews add time beyond standard M&A timelines.
- Healthcare services trade at 6x-14x EBITDA depending on payer mix and subsector. Your advisor benchmarks your specific profile.
- Healthcare-only advisors win more. Buyers spot clinical and regulatory gaps faster than generalist advisors can cover them.
- Payer contracts, revenue cycle reports, and compliance audits come before financials. Prepare these before advisor outreach.
